ID   RGPA2_HUMAN             Reviewed;        1873 AA.
AC   Q2PPJ7; Q4VXU6; Q5JUA3; Q5JUA4; Q5T9K3; Q96CX9; Q9BQT7; Q9H9D9; Q9ULE8;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 2.
DT   28-JUN-2023, entry version 136.
DE   RecName: Full=Ral GTPase-activating protein subunit alpha-2;
DE   AltName: Full=250 kDa substrate of Akt;
DE            Short=AS250;
DE   AltName: Full=p220;
GN   Name=RALGAPA2; Synonyms=C20orf74, KIAA1272;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH RALGAPB,
RP   SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-486; SER-696 AND THR-715.
RX   PubMed=16490346; DOI=10.1016/j.cellsig.2006.01.002;
RA   Gridley S., Chavez J.A., Lane W.S., Lienhard G.E.;
RT   "Adipocytes contain a novel complex similar to the tuberous sclerosis
RT   complex.";
RL   Cell. Signal. 18:1626-1632(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 813-1873 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1539-1873 (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1571-1873 (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-820 AND SER-821, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-820 AND SER-821, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486; SER-696; SER-820 AND
RP   SER-821, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-486; SER-820 AND SER-1593,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalytic subunit of the heterodimeric RalGAP2 complex which
CC       acts as a GTPase activator for the Ras-like small GTPases RALA and
CC       RALB. {ECO:0000250}.
CC   -!- SUBUNIT: Component of the heterodimeric RalGAP2 complex with RALGAPB.
CC       Heterodimerization is required for activity (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q2PPJ7; Q8WTU0: DDI1; NbExp=3; IntAct=EBI-9519763, EBI-748248;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16490346}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q2PPJ7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2PPJ7-2; Sequence=VSP_025247;
CC       Name=3;
CC         IsoId=Q2PPJ7-3; Sequence=VSP_025248;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH13749.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB14290.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ310704; ABC33805.1; -; mRNA.
DR   EMBL; AL078634; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL121896; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157718; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL161658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB033098; BAA86586.1; -; mRNA.
DR   EMBL; AK022881; BAB14290.1; ALT_INIT; mRNA.
DR   EMBL; BC013749; AAH13749.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS46584.1; -. [Q2PPJ7-1]
DR   RefSeq; NP_065076.2; NM_020343.3. [Q2PPJ7-1]
DR   AlphaFoldDB; Q2PPJ7; -.
DR   SMR; Q2PPJ7; -.
DR   BioGRID; 121435; 32.
DR   IntAct; Q2PPJ7; 8.
DR   MINT; Q2PPJ7; -.
DR   STRING; 9606.ENSP00000202677; -.
DR   GlyGen; Q2PPJ7; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q2PPJ7; -.
DR   PhosphoSitePlus; Q2PPJ7; -.
DR   SwissPalm; Q2PPJ7; -.
DR   BioMuta; RALGAPA2; -.
DR   DMDM; 147742932; -.
DR   EPD; Q2PPJ7; -.
DR   jPOST; Q2PPJ7; -.
DR   MassIVE; Q2PPJ7; -.
DR   MaxQB; Q2PPJ7; -.
DR   PaxDb; Q2PPJ7; -.
DR   PeptideAtlas; Q2PPJ7; -.
DR   ProteomicsDB; 61429; -. [Q2PPJ7-1]
DR   ProteomicsDB; 61430; -. [Q2PPJ7-2]
DR   ProteomicsDB; 61431; -. [Q2PPJ7-3]
DR   Antibodypedia; 59154; 68 antibodies from 16 providers.
DR   DNASU; 57186; -.
DR   Ensembl; ENST00000202677.12; ENSP00000202677.6; ENSG00000188559.16. [Q2PPJ7-1]
DR   GeneID; 57186; -.
DR   KEGG; hsa:57186; -.
DR   MANE-Select; ENST00000202677.12; ENSP00000202677.6; NM_020343.4; NP_065076.2.
DR   UCSC; uc002wrz.4; human. [Q2PPJ7-1]
DR   AGR; HGNC:16207; -.
DR   CTD; 57186; -.
DR   DisGeNET; 57186; -.
DR   GeneCards; RALGAPA2; -.
DR   HGNC; HGNC:16207; RALGAPA2.
DR   HPA; ENSG00000188559; Low tissue specificity.
DR   MIM; 618836; gene.
DR   neXtProt; NX_Q2PPJ7; -.
DR   OpenTargets; ENSG00000188559; -.
DR   PharmGKB; PA25784; -.
DR   VEuPathDB; HostDB:ENSG00000188559; -.
DR   eggNOG; KOG3686; Eukaryota.
DR   GeneTree; ENSGT00950000183139; -.
DR   HOGENOM; CLU_001676_0_0_1; -.
DR   InParanoid; Q2PPJ7; -.
DR   OMA; ELMRNGW; -.
DR   OrthoDB; 21929at2759; -.
DR   PhylomeDB; Q2PPJ7; -.
DR   TreeFam; TF324484; -.
DR   PathwayCommons; Q2PPJ7; -.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   SignaLink; Q2PPJ7; -.
DR   SIGNOR; Q2PPJ7; -.
DR   BioGRID-ORCS; 57186; 17 hits in 1171 CRISPR screens.
DR   ChiTaRS; RALGAPA2; human.
DR   GenomeRNAi; 57186; -.
DR   Pharos; Q2PPJ7; Tdark.
DR   PRO; PR:Q2PPJ7; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q2PPJ7; protein.
DR   Bgee; ENSG00000188559; Expressed in tibialis anterior and 185 other tissues.
DR   ExpressionAtlas; Q2PPJ7; baseline and differential.
DR   Genevisible; Q2PPJ7; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005096; F:GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0090630; P:activation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro.
DR   Gene3D; 3.40.50.11210; Rap/Ran-GAP; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR035974; Rap/Ran-GAP_sf.
DR   InterPro; IPR000331; Rap/Ran_GAP_dom.
DR   InterPro; IPR046859; RGPA/RALGAPB_N.
DR   InterPro; IPR027107; Tuberin/Ral-act_asu.
DR   PANTHER; PTHR10063:SF2; RAL GTPASE-ACTIVATING PROTEIN SUBUNIT ALPHA-2; 1.
DR   PANTHER; PTHR10063; TUBERIN; 1.
DR   Pfam; PF20412; RALGAPB_N; 1.
DR   Pfam; PF02145; Rap_GAP; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF111347; Rap/Ran-GAP; 1.
DR   PROSITE; PS50085; RAPGAP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; GTPase activation; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1873
FT                   /note="Ral GTPase-activating protein subunit alpha-2"
FT                   /id="PRO_0000286972"
FT   DOMAIN          1635..1843
FT                   /note="Rap-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00165"
FT   REGION          341..370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          445..481
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          734..856
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        356..370
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        445..473
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        738..799
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        800..814
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        822..846
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A3KGS3"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A3KGS3"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A3KGS3"
FT   MOD_RES         486
FT                   /note="Phosphoserine; by PKB"
FT                   /evidence="ECO:0000269|PubMed:16490346,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         696
FT                   /note="Phosphoserine; by PKB"
FT                   /evidence="ECO:0000269|PubMed:16490346,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         715
FT                   /note="Phosphothreonine; by PKB"
FT                   /evidence="ECO:0000269|PubMed:16490346"
FT   MOD_RES         820
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         821
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1593
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1832..1873
FT                   /note="FYEERALYLEAIIQNHREVMTFEDFAAQVFSPSPSYSLSGTD -> LYLFAL
FT                   NV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_025247"
FT   VAR_SEQ         1832..1873
FT                   /note="FYEERALYLEAIIQNHREVMTFEDFAAQVFSPSPSYSLSGTD -> PRVR
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10574462"
FT                   /id="VSP_025248"
FT   VARIANT         492
FT                   /note="S -> N (in dbSNP:rs6137081)"
FT                   /id="VAR_049157"
FT   CONFLICT        1488
FT                   /note="N -> S (in Ref. 1; ABC33805 and 3; BAA86586)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1873 AA;  210770 MW;  DC33C087B4802541 CRC64;
     MFSRRSHGDV KKSTQKVLDP KKDVLTRLKH LRALLDNVDA NDLKQFFETN YSQIYFIFYE
     NFIALENSLK LKGNNKSQRE ELDSILFLFE KILQFLPERI FFRWHYQSIG STLKKLLHTG
     NSIKIRCEGI RLFLLWLQAL QTNCAEEQVL IFACLVPGFP AVMSSRGPCT LETLINPSPS
     VADVKIYPEE ITPLLPAISG EKIAEDQTCF FLQILLKYMV IQAASLEWKN KENQDTGFKF
     LFTLFRKYYL PHLFPSFTKL TNIYKPVLDI PHLRPKPVYI TTTRDNENIY STKIPYMAAR
     VVFIKWIVTF FLEKKYLTAT QNTKNGVDVL PKIIQTVGGG AVQERAPELD GGGPTEQDKS
     HSNSSTLSDR RLSNSSLCSI EEEHRMVYEM VQRILLSTRG YVNFVNEVFH QAFLLPSCEI
     AVTRKVVQVY RKWILQDKPV FMEEPDRKDV AQEDAEKLGF SETDSKEASS ESSGHKRSSS
     WGRTYSFTSA MSRGCVTEEE NTNVKAGVQA LLQVFLTNSA NIFLLEPCAE VPVLLKEQVD
     ACKAVLIIFR RMIMELTMNK KTWEQMLQIL LRITEAVMQK PKDKQIKDLF AQSLAGLLFR
     TLMVAWIRAN LCVYISRELW DDFLGVLSSL TEWEELINEW ANIMDSLTAV LARTVYGVEM
     TNLPLDKLSE QKEKKQRGKG CVLDPQKGTT VGRSFSLSWR SHPDVTEPMR FRSATTSGAP
     GVEKARNIVR QKATEVEECQ QSENAPAAGS GHLTVGQQQQ VLRSSSTSDI PEPLCSDSSQ
     GQKAENTQNS SSSEPQPIQE NKGHVKREHE GITILVRRSS SPAELDLKDD LQQTQGKCRE
     RQKSESTNSD TTLGCTNEAE LSMGPWQTCE EDPELNTPTD VVADADARHW LQLSPTDASN
     LTDSSECLTD DCSIIAGGSL TGWHPDSAAV LWRRVLGILG DVNNIQSPKI HARVFCYLYE
     LWYKLAKIRD NLAISLDNQS SPSPPVLIPP LRMFASWLFK AATLPNEYKE GKLQAYRLIC
     AMMTRRQDVL PNSDFLVHFY LVMHLGLTSE DQDILNTIIR HCPPRFFSLG FPGFSMLVGD
     FITAAARVLS TDILTAPRSE AVTVLGSLVC FPNTYQEIPL LQSVPEVNEA ITGTEDVKHY
     LINILLKNAT EEPNEYARCI AVCSLGVWIC EELAQCTSHP QVKEAINVIG VTLKFPNKIV
     AQVACDVLQL LVSYWEKLQM FETSLPRKMA EILVATVAFL LPSAEYSSVE TDKKFIVSLL
     LCLLDWCMAL PVSVLLHPVS TAVLEEQHSA RAPLLDYIYR VLHCCVCGSS TYTQQSHYIL
     TLADLSSTDY DPFLPLANVK SSEPVQYHSS AELGNLLTVE EEKKRRSLEL IPLTARMVMA
     HLVNHLGHYP LSGGPAILHS LVSENHDNAH VEGSELSFEV FRSPNLQLFV FNDSTLISYL
     QTPTEGPVGG SPVGSLSDVR VIVRDISGKY SWDGKVLYGP LEGCLAPNGR NPSFLISSWH
     RDTFGPQKDS SQVEEGDDVL DKLLENIGHT SPECLLPSQL NLNEPSLTPC GMNYDQEKEI
     IEVILRQNAQ EDEYIQSHNF DSAMKVTSQG QPSPVEPRGP FYFCRLLLDD LGMNSWDRRK
     NFHLLKKNSK LLRELKNLDS RQCRETHKIA VFYIAEGQED KCSILSNERG SQAYEDFVAG
     LGWEVDLSTH CGFMGGLQRN GSTGQTAPYY ATSTVEVIFH VSTRMPSDSD DSLTKKLRHL
     GNDEVHIVWS EHSRDYRRGI IPTAFGDVSI IIYPMKNHMF FIAITKKPEV PFFGPLFDGA
     IVSGKLLPSL VCATCINASR AVKCLIPLYQ SFYEERALYL EAIIQNHREV MTFEDFAAQV
     FSPSPSYSLS GTD
//
